SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line

  • Authors:
    • Daniela Bellarosa
    • Alessandro Bressan
    • Mario Bigioni
    • Massimo Parlani
    • Carlo Alberto Maggi
    • Monica Binaschi
  • View Affiliations

  • Published online on: July 13, 2012     https://doi.org/10.3892/ijo.2012.1551
  • Pages: 1486-1494
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

HDAC inhibitors (HDACis) represent a class of anticancer agents including suberoylanilide hydroxamic acid (SAHA, Vorinostat), which has shown a strong antitumor effect, both in vitro and in vivo. Induction of apoptotic genes is an important pathway of SAHA cytotoxic mechanism of action and it has been largely described that SAHA induces sensitization of cell death receptor-resistant breast cancer cells to apoptosis. In this study, we investigated the activation of some apoptotic genes which could be responsible for the in vivo antitumor potency of SAHA in a model of human breast cancer. We found that the apoptotic gene pattern induced by SAHA in the MDA-MB-231 cell line involves the upregulation of some molecules belonging to the TNF superfamily. In particular, we demonstrated that the upregulation of the CD137 receptor/ligand system correlates with a synergistic cytotoxic effect when MDA-MB-231 cells are treated with the combination of SAHA and soluble CD137 receptor. To our knowledge, this is the first study to indicate that this member of the TNF superfamily, CD137, is modulated by SAHA treatment in breast cancer cells, suggesting that the combination of SAHA with this TNF-related receptor could be a new therapeutic approach for the treatment of tumors.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 41 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bellarosa D, Bressan A, Bigioni M, Parlani M, Maggi CA and Binaschi M: SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line . Int J Oncol 41: 1486-1494, 2012
APA
Bellarosa, D., Bressan, A., Bigioni, M., Parlani, M., Maggi, C.A., & Binaschi, M. (2012). SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line . International Journal of Oncology, 41, 1486-1494. https://doi.org/10.3892/ijo.2012.1551
MLA
Bellarosa, D., Bressan, A., Bigioni, M., Parlani, M., Maggi, C. A., Binaschi, M."SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line ". International Journal of Oncology 41.4 (2012): 1486-1494.
Chicago
Bellarosa, D., Bressan, A., Bigioni, M., Parlani, M., Maggi, C. A., Binaschi, M."SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line ". International Journal of Oncology 41, no. 4 (2012): 1486-1494. https://doi.org/10.3892/ijo.2012.1551